Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.

ABSTRACT:

Objectives

To demonstrate acceptability and operational feasibility of introducing human papillomavirus (HPV) testing as a principal cervical cancer screening method in public health programmes in sub-Saharan Africa.

Setting

45 primary and secondary health clinics in Malawi, Nigeria, Senegal, Uganda and Zimbabwe.

Participants

15 766 women aged 25-54 years presenting at outpatient departments (Senegal only, general population) or at antiretroviral therapy clinics (all other countries, HIV-positive women only). Eligibility criteria followed national guidelines for cervical cancer screening.

Interventions

HPV testing was offered to eligible women as a primary screening for cervical cancer, and HPV-positive women were referred for visual inspection with acetic acid

SUBMITTER: Joseph J 

PROVIDER: S-EPMC9827237 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature